Hyperventilation assists proarrhythmia development during delayed repolarization in clofilium-treated, anaesthetized,...

Area of Science:

• Cardiovascular Physiology
• Pharmacology
• Electrophysiology

Background:

• Hyperventilation reduces blood CO2 (PCO2), leading to hypokalemia.
• Hypokalemia is linked to life-threatening ventricular arrhythmias, particularly Torsades de Pointes (TdP).
• Repolarization-delaying drugs can exacerbate arrhythmia risk.

Purpose of the Study:

• To experimentally investigate how hyperventilation affects proarrhythmia development.
• To determine the role of PCO2 and serum potassium in drug-induced arrhythmias.
• To assess the impact of hyperventilation on TdP onset and incidence.

Main Methods:

• Mechanically ventilated rabbits received phenylephrine and clofilium (a repolarization-delaying agent).
• ECG, serum K+, pH, and PCO2 were monitored.
• Animals were divided into TdP+ and TdP- groups based on arrhythmia occurrence.

Main Results:

• Clofilium prolonged the QT interval, indicating delayed repolarization.
• A positive correlation existed between serum K+, PCO2, and arrhythmia onset time.
• Lower PCO2 and K+ correlated with earlier arrhythmia onset, especially in the TdP+ group.

Conclusions:

• Hyperventilation, hypocapnia, and hypokalemia contribute to proarrhythmia development during delayed repolarization.
• Tight control of PCO2 and serum K+ is essential in experimental and clinical settings with repolarization-delaying drugs.
• Findings highlight the multifactorial nature of drug-induced arrhythmias.